← SynDRA
PINOMETOSTAT
SynDRA canonical compound SYN0038141 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | DOT1L |
|---|
| Mechanism of action | DOT1L inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- DOT1L INHIBITOR
- histone lysine methyltransferase inhibitor
- DOT1L MODULATOR
Cross-references
Synonyms
- Pinometostat anhydrous
- EPZ-005676
- EPZ-5676
- EPZ5676
- UNII-8V9YR09EF3
- UNII-F66X4M38G5
- 8V9YR09EF3
- CHEMBL3087499
- CHEMBL3414626
- F66X4M38G5
- (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol
- Pinometostat, trans-
- 5'-[{cis-3-[2-(5-Tert-Butyl-1h-Benzimidazol-2-Yl)ethyl]cyclobutyl}(Propan-2-Yl)amino]-5'-Deoxyadenosine
- EPZ 5676
Look up PINOMETOSTAT in the interactive SynDRA portal →